PROSTATE-SPECIFIC ANTIGEN AFTER RADIATION THERAPY: Prognosis by Pretreatment Level and Post-treatment Nadir
- 1 May 1997
- journal article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 24 (2) , 407-414
- https://doi.org/10.1016/s0094-0143(05)70387-6
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- 2 Conformal technique dose escalation in prostate cancer: improved cancer control with higher doses in patients with pretreatment PSA 10 ngm/mlInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Reference range for prostate-specific antigen levels after external beam radiation therapy for adenocarcinoma of the prostateUrology, 1995
- New biological functions of prostate-specific antigen?Journal of Clinical Endocrinology & Metabolism, 1995
- Prostate specific antigen-monitored combination radiotherapy for patients with prostate cancer. I-125 implant followed by external-beam radiationCancer, 1995
- Control of Prostate Cancer with Radiotherapy: Long-Term ResultsJournal of Urology, 1994
- Changes in immunohistochemical staining of PSA, PAP, and TURP-27 following irradiation therapy for clinically localized prostate cancerUrology, 1994
- Patterns of care and rtog studies in prostate cancer: Long-term survival, hazard rate observations, and possibilities of cureInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Serum prostate-specific antigen in monitoring the response of carcinoma of the prostate to radiation therapyRadiotherapy and Oncology, 1992
- Evaluation of Tumor Progression by Repeated Fine Needle Biopsies in Prostate Adenocarcinoma: Modal Deoxyribonucleic Acid Value and Cytological DifferentiationJournal of Urology, 1990
- The dedifferentiation of prostate carcinomaCancer, 1983